118 related articles for article (PubMed ID: 1886907)
1. Effects of the PAF-analog and -antagonist CV-6209 on cultured human glioma cell lines.
Gáti I; Bergström M; Muhr C; Carlsson J
Prostaglandins Leukot Essent Fatty Acids; 1991 Jun; 43(2):103-10. PubMed ID: 1886907
[TBL] [Abstract][Full Text] [Related]
2. Application of (methyl-11C)-methionine in the multicellular spheroid system.
Gáti I; Bergström M; Muhr C; Långström B; Carlsson J
J Nucl Med; 1991 Dec; 32(12):2258-65. PubMed ID: 1744712
[TBL] [Abstract][Full Text] [Related]
3. CV-6209, a highly potent antagonist of platelet activating factor in vitro and in vivo.
Terashita Z; Imura Y; Takatani M; Tsushima S; Nishikawa K
J Pharmacol Exp Ther; 1987 Jul; 242(1):263-8. PubMed ID: 3612533
[TBL] [Abstract][Full Text] [Related]
4. Beneficial effects of TCV-309, a novel potent and selective platelet activating factor antagonist in endotoxin and anaphylactic shock in rodents.
Terashita Z; Kawamura M; Takatani M; Tsushima S; Imura Y; Nishikawa K
J Pharmacol Exp Ther; 1992 Feb; 260(2):748-55. PubMed ID: 1738121
[TBL] [Abstract][Full Text] [Related]
5. Some antagonists of platelet activating factor are cytotoxic for human malignant cell lines.
Danhauser-Riedl S; Felix SB; Houlihan WJ; Zafferani M; Steinhauser G; Oberberg D; Kalvelage H; Busch R; Rastetter J; Berdel WE
Cancer Res; 1991 Jan; 51(1):43-8. PubMed ID: 1988103
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of neutrophil respiratory burst and degranulation responses to platelet-activating factor by antagonists WEB 2086, CV 6209 and CV 3988.
Bates EJ; Harvey DP; Ferrante A
Int Arch Allergy Immunol; 1992; 97(1):50-6. PubMed ID: 1582698
[TBL] [Abstract][Full Text] [Related]
7. Leukotriene and 5-lipoxygenase inhibitor induced variations in thymidine uptake in a human glioma cell line cultured as monolayers or as multicellular spheroids.
Gáti I; Bergström M; Muhr C; Carlsson J
Anticancer Res; 1994; 14(2A):453-9. PubMed ID: 8017847
[TBL] [Abstract][Full Text] [Related]
8. Calcium ion mobilization in neuronal cells induced by PAF.
Kornecki E; Ehrlich YH
Lipids; 1991 Dec; 26(12):1243-6. PubMed ID: 1819710
[TBL] [Abstract][Full Text] [Related]
9. Antagonism of platelet activating factor receptor binding and stimulated phosphoinositide-specific phospholipase C in rabbit platelets.
Morrison WJ; Shukla SD
J Pharmacol Exp Ther; 1989 Sep; 250(3):831-5. PubMed ID: 2550620
[TBL] [Abstract][Full Text] [Related]
10. Two different sites of action for platelet activating factor and 1-O-alkyl-2-O-methyl-sn-glycero-3-phosphocholine on platelets and leukemic cells.
Salari H; Dryden P; Howard S; Bittman R
Biochem Cell Biol; 1992 Feb; 70(2):129-35. PubMed ID: 1324692
[TBL] [Abstract][Full Text] [Related]
11. Lack of correlation between cytotoxicity of agonists and antagonists of platelet activating factor [paf-acether] in neoplastic cells and modulation of [3H]-paf-acether binding to platelets from humans in vitro.
Berdel WE; Korth R; Reichert A; Houlihan WJ; Bicker U; Nomura H; Vogler WR; Benveniste J; Rastetter J
Anticancer Res; 1987; 7(6):1181-7. PubMed ID: 3442414
[TBL] [Abstract][Full Text] [Related]
12. CV 6209 is a non-competitive antagonist of platelet-activating factor receptors on guinea-pig resident peritoneal macrophages.
Stewart AG
Clin Exp Pharmacol Physiol; 1989 Nov; 16(11):813-20. PubMed ID: 2558827
[TBL] [Abstract][Full Text] [Related]
13. Inhibitory effect of TCV-309, a novel platelet activating factor (PAF) antagonist, on endotoxin-induced disseminated intravascular coagulation in rats: possible role of PAF in tissue factor generation.
Kawamura M; Terashita Z; Imura Y; Shino A; Nishikawa K
Thromb Res; 1993 May; 70(4):281-93. PubMed ID: 8332959
[TBL] [Abstract][Full Text] [Related]
14. Effect of platelet-activating factor on lipoprotein lipase and blood lipids.
Mimura K; Yukawa S; Mori Y; Okada K; Mune M; Nishikawa O; Hibino A; Sonobe M; Goto T; Nomoto H
Lipids; 1991 Dec; 26(12):1102-7. PubMed ID: 1819694
[TBL] [Abstract][Full Text] [Related]
15. Analogues of platelet activating factor. 8. Antagonists of PAF containing an aromatic ring linked to a pyridinium ring.
Trova MP; Wissner A; Carroll ML; Kerwar SS; Pickett WC; Schaub RE; Torley LW; Kohler CA
J Med Chem; 1993 Mar; 36(5):580-90. PubMed ID: 8496938
[TBL] [Abstract][Full Text] [Related]
16. Effects of the 5-lipoxygenase inhibitors AA-863 and U-60,257 on human glioma cell lines.
Gáti I; Bergström M; Csóka K; Muhr C; Carlsson J
Prostaglandins Leukot Essent Fatty Acids; 1990 Jun; 40(2):117-24. PubMed ID: 2117290
[TBL] [Abstract][Full Text] [Related]
17. Platelet-activating factor induces cell growth through tyrosine phosphorylation pathway in cultured rat mesangial cells.
Komatsu H; Ishiwari K; Shikata A; Nishida M; Kawakatsu H; Sawada T
Nihon Jinzo Gakkai Shi; 1995 Nov; 37(11):622-31. PubMed ID: 8583698
[TBL] [Abstract][Full Text] [Related]
18. The effects of human recombinant tumor necrosis factor on glioma-derived cell lines: cellular proliferation, cytotoxicity, morphological and radioreceptor studies.
Rutka JT; Giblin JR; Berens ME; Bar-Shiva E; Tokuda K; McCulloch JR; Rosenblum ML; Eessalu TE; Aggarwal BB; Bodell WJ
Int J Cancer; 1988 Apr; 41(4):573-82. PubMed ID: 2833452
[TBL] [Abstract][Full Text] [Related]
19. Effects of the platelet-activating factor antagonists CV-6209 and CV-3988 on nephrotoxic serum nephritis in the rat.
Iida H; Fujita M; Izumino K; Asaka M; Entani C; Takata M; Sasayama S
Nephron; 1992; 60(4):471-6. PubMed ID: 1584324
[TBL] [Abstract][Full Text] [Related]
20. Pregnancy suppression by a structurally related antagonist for platelet activating factor, CV-6209, in mice.
Ando M; Suginami H; Matsuura S
Asia Oceania J Obstet Gynaecol; 1990 Sep; 16(3):283-90. PubMed ID: 2088253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
